Clinical Trial: The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vitamin C Levels

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652346) titled 'The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vitamin C Levels' on June 10.

Brief Summary: This is a randomized, double-blind, placebo-controlled, parallel-group, study evaluating the effect of a Qualia Vitamin C+ formulation on Whole Blood Vitamin C levels in the blood of healthy adults aged 25 years or older that have suboptimal vitamin C blood levels (i.e., 0.4 - 0.9 mg/dL) and those with adequate vitamin C blood levels (>=0.9 mg/dL). Approximately 152 (76 in the suboptimal stratum and 76 in the adequate stratum) participants will be randomized to one of two study arms: Qualia Vitamin C+ or placebo. ...